D-Glucose-6-phosphate (sodium salt)

D-Glucose-6-phosphate (sodium salt)

CAT N°: 20376
Price:

From 48.00 40.80

D-Glucose-6-phosphate is formed in cells when glucose is phosphorylated by hexokinase (or glucokinase) or by the conversion of glucose-1-phosphate by phosphoglucomutase, which is the first step of glycogen synthesis.{20949} It is stored as glycogen when blood glucose levels are high. Disruption of D-glucose-6-phosphate activity leads to glycogen storage disease type I or von Gierke’s disease, a group of inherited metabolic diseases characterized by severe hypoglycemia, growth retardation, and hepatomegaly, due to accumulation of glycogen and fat in the liver.{19698,19697} D-Glucose-6-phosphate is also the starting molecule of both glycolysis and the pentose phosphate pathways.{19695} Because cancer cells adopt glycolysis as a major source of metabolic energy production, and the pentose phosphate pathway plays a role in helping glycolytic cancer cells to meet their anabolic demands, this compound can be used to study the progression of this process.{26683}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • D-glucose-6-(dihydrogen phosphate), monosodium salt
  • Correlated keywords
    • 3671-99-6 56-73-5 3615-49-4 phosphorylated hexokinase glucokinase phosphoglucomutase glycogen synthesis hypoglycemia hepatomegaly glycolysis gluconeogenesis
  • Product Overview:
    D-Glucose-6-phosphate is formed in cells when glucose is phosphorylated by hexokinase (or glucokinase) or by the conversion of glucose-1-phosphate by phosphoglucomutase, which is the first step of glycogen synthesis.{20949} It is stored as glycogen when blood glucose levels are high. Disruption of D-glucose-6-phosphate activity leads to glycogen storage disease type I or von Gierke’s disease, a group of inherited metabolic diseases characterized by severe hypoglycemia, growth retardation, and hepatomegaly, due to accumulation of glycogen and fat in the liver.{19698,19697} D-Glucose-6-phosphate is also the starting molecule of both glycolysis and the pentose phosphate pathways.{19695} Because cancer cells adopt glycolysis as a major source of metabolic energy production, and the pentose phosphate pathway plays a role in helping glycolytic cancer cells to meet their anabolic demands, this compound can be used to study the progression of this process.{26683}

We also advise you